1. Home
  2. MLYS vs ESQ Comparison

MLYS vs ESQ Comparison

Compare MLYS & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$37.07

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$105.03

Market Cap

858.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
ESQ
Founded
2019
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
858.2M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
MLYS
ESQ
Price
$37.07
$105.03
Analyst Decision
Strong Buy
Hold
Analyst Count
7
3
Target Price
$47.33
$113.00
AVG Volume (30 Days)
1.5M
61.1K
Earning Date
02-11-2026
01-22-2026
Dividend Yield
N/A
0.67%
EPS Growth
N/A
14.70
EPS
N/A
5.68
Revenue
N/A
$131,743,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.55
P/E Ratio
N/A
$18.50
Revenue Growth
N/A
13.37
52 Week Low
$8.24
$68.90
52 Week High
$47.65
$110.71

Technical Indicators

Market Signals
Indicator
MLYS
ESQ
Relative Strength Index (RSI) 43.16 55.75
Support Level $36.50 $105.50
Resistance Level $38.23 $110.71
Average True Range (ATR) 1.68 2.71
MACD 0.09 -0.23
Stochastic Oscillator 41.96 50.11

Price Performance

Historical Comparison
MLYS
ESQ

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

Share on Social Networks: